🇲🇾 Going to #WFH2026? Bleeding Disorders: Care & Practice's Editor-in-Chief, Maria Santaella, will be there. You can connect with Maria to find out more about the journal via the conference app.
#BDCP #bleedingdisorders #Haemnet
#HemeSky @medsky.social
🩸 People living with #SCD needs coordinated care. ASH and 76 partner organizations have urged Congress to pass the bipartisan Sickle Cell Disease Comprehensive Care Act (S.721/H.R.5178). Read the letter: https://ow.ly/nnQL50YLmwj #ConquerSCD #HemeSky
A new study provides hope for older adults with newly diagnosed B-cell acute lymphoblastic leukemia, showing the promise of a chemotherapy-free regimen.
Read more in The Hematologist: https://ow.ly/Oc8S50YLmQU
#HemeSky #HemeOnc
Meet Robert Negrin, MD, 2026 President of ASH and Professor at Stanford University. A leading physician-scientist, he advances transplantation, immunology, and supports the next generation of hematologists. Learn more: https://ow.ly/gQbh50YLaX3
#HemeSky #MedSky
Join us as we judge cells by their cover in the haematological pageant of dysplasia, as we bravely attempt to cover morphology in an entirely audio format #hemesky #meded #dysplasia #nucleusworldchampionship2026
www.bloodyminded.com.au/allepisodes/...
If you have a bleeding disorder but no diagnosis, how can you access the care & treatment you need? Over 75% of people with bleeding disorders globally aren't diagnosed. On #WorldHemophiliaDay, we're joining the call to improve diagnostic capacity. https://loom.ly/ZKyP0To
#WHD2026 #HemeSky #MedSky
Accurate diagnosis is critical in myelodysplastic neoplasms (MDS). In this new HemeTalks episode, learn current diagnostic standards using advanced molecular techniques and how precise risk assessment drives better clinical decisions. 🔗 https://ow.ly/TZN350YF3Q4
#HemeSky #MedSky ASH Education
Specialty Switcheroo: Big career moves are not uncommon among #nurse practitioners (NPs) and #physician associates (PAs). Surveys found that one-third of NPs and PAs have changed specialties at least once during their career.
#HemeSky #MedSky
Are you a dedicated ASH member with a passion for service, leadership, and shaping the future of our Society? ASH is seeking dynamic, committed members, both early-career and established, to serve in committee positions or leadership roles.
Submit now: https://ow.ly/x5vN50YK5Zr
#HemeSky #MedSky
The JAK inhibitor #ruxolitinib was found to alleviate severe intractable diarrhea following treatment with cilta-cel in a small series of patients with #MultipleMyeloma #MMsm, offering clinical improvement to patients experiencing symptoms: https://ow.ly/u7Jc50YFG8g
#HemeSky #MedSky #myeloma
Sickle cell disease is the most common inherited blood disorder worldwide, but experiences vary by region. SWAY data show individuals in sub-Saharan Africa are less likely to know their variant or use standard treatments.
Learn more in the press release: https://ow.ly/S0bM50YISHV
#HemeSky
‘Diagnosis – First step to care’ is the #WHD2026 theme. Morris Okello was diagnosed with #haemophilia as a teenager. Ahead of #WorldHemophiliaDay on 17 April, find out what diagnosis meant for him: https://loom.ly/5AMZ2xE
#HemeSky
@medsky.social
📢 Last chance to apply for the ASH and @fda.gov workshop on regulatory science in #hematology! Learn about FDA’s role, IND process, and more.
Apply today: https://ow.ly/EwmX50YGsnH
#Hemesky #Medsky #hemeonc
New research indicates that #ctDNA may be a robust prognostic biomarker for #LBCL. Using phased-variant MRD post-treatment, researchers found that clearance of MRD was consistently associated with low rates of #tumor recurrence across all groups tested: https://ow.ly/I2UQ50YFF1k
#HemeSky #lymphoma
Aplastic anemia is a serious bone marrow failure syndrome that remains underrecognized. In the latest LARAA webinar, experts share practical strategies to improve diagnosis, treatment and access to care in Latin America.
🔗 https://ow.ly/CgMA50YHf13
#HemeSky #Anemia #BMFSM
While oral iron is used often to treat #IronDeficiency in patients with heavy #menstrual bleeding, new findings reveal that IV iron is more cost-effective across the reproductive lifespan, with an incremental cost-effectiveness ratio of $28,600/QALY: https://ow.ly/in4C50YFEHR
#HemeSky #anemia
Hematology needs strong voices now more than ever. The Advocacy Leadership Institute builds meaningful policy engagement skills and help elevate the voice of hematology in DC.
🔗https://ow.ly/8Hl350YH0LY
#MedSky #HemeSky
Application closing this week!
MEI is more than training — it’s your laboratory to experiment, innovate, and grow as a hematology educator.
Apply by April 16: https://ow.ly/woVj50YEXLB
#ASHEducation #ASHTrainee #HemeSky #Medsky
The April issue has arrived! Issue highlights include the use of #AI in #clinical care, cost effectiveness of IV #iron for iron-deficient women with heavy #menstrual bleeding, #ctDNA as a prognostic biomarker for #LBCL, and more. See the full lineup here: https://ow.ly/bZvq50YEywg
#HemeSky #MedSky
New ep today on the must-know APML, and due to popular demand we of course bring you Nicholas doing spoken word poetry #hemesky #APML #meded #sorryjodi
www.bloodyminded.com.au/allepisodes/...
New on #Haemcast: members of #LFWBD discuss talking to their children about their #bleedingdisorder — and how their concerns aren't always what you might expect.
On podcast platforms, YouTube & here:
https://loom.ly/uvvmvQk
#haemophilia #families #children #podcast
#HemeSky #MedSky
Findings from a retrospective study on trends in #hydroxyurea (HU) use in #pediatric #SCD following the 2014 #NHLBI guidelines suggest that a lower age of HU initiation may have contributed to a decrease in #cerebrovascular disease: https://ow.ly/LHy050YCneB
#HemeSky #SickleCellDisease
Step into the science! ASH Scientific Committees are looking for members to guide the Annual Meeting program, highlight novel research, and advance interdisciplinary discoveries in hematology.
Nominate yourself or a colleague: https://ow.ly/ycwS50YCmHE
#HemeSky #MedSky
How does the ASH SCD Away Elective Rotation make an impact? Hear from a past participant!
This one-month immersive rotation offers hands-on #SickleCellDisease training in both inpatient and outpatient care.
Apply now: https://ow.ly/1sri50YCYab
#SickleCell #SCD #HemeSky
ASH strongly opposes the Administration’s proposed 12.3% cut to NIH. These reductions would devastate hematology research, harm patients, & undermine U.S. leadership in medical innovation. 🔗 https://ow.ly/t4YJ50YCXlC
#Fight4Hematology #HemeSky #ASHinaFlash
Growing the #Workforce: To address the #physician shortage, the Centers for Medicare & Medicaid Services is funding 400 new #medical residency positions across the country. Most of the positions will go to primary care and psychiatry programs.
#MedSky #HemeSky
With digital microscopy and AI expanding into the field of hematopathology, a new article in The Hematologist explores the current state and future promise of digital morphology in bone marrow analysis. Read now: https://ow.ly/VQfi50YCmcL
#HemeSky #MedSky
Too many people with sickle cell disease face fragmented care. Congress can fix this. Urge your Senators and Representatives to cosponsor the Sickle Cell Disease Comprehensive Care Act (S.721/H.R.5178) today!
Act now: https://ow.ly/sbUw50YCiEs
#SCD #SCDCCA #HemeSky
In patients with R/R follicular #lymphoma, treatment with the triplet combo of #tafasitamab, #lenalidomide, and #rituximab led to significantly improved PFS compared with the SOC combo of lenalidomide plus rituximab, at a median 22.4 months vs. 13.9: https://ow.ly/PSaT50YBgcw
#HemeSky
